Literature DB >> 16699380

The naturalistic course of unipolar major depression in the absence of somatic therapy.

Michael A Posternak1, David A Solomon, Andrew C Leon, Timothy I Mueller, M Tracie Shea, Jean Endicott, Martin B Keller.   

Abstract

The goal of the study was to describe the naturalistic course of unipolar major depression in subjects not receiving somatic therapy for their depressive illness. Affectively ill individuals were recruited into the Collaborative Depression Study and followed prospectively for up to 15 years. One hundred thirty subjects who recovered from their intake episode of major depression subsequently experienced a recurrence that went untreated for at least 4 weeks following onset of the recurrence. The duration of the recurrent episode was examined using survival analytic techniques. Of the 130 subjects, 46 obtained somatic therapy at some time during the course of their depressive illness, while 84 subjects received no somatic therapy throughout their entire depressive episode. Survival analysis, which accounts for these 46 individuals by censoring their episodes at the time treatment was obtained, yielded a median time to recovery of 23 weeks. In the subsample of 84 subjects whose depressive illness went untreated from its inception through its resolution, the median time to recovery was 13 weeks. These results suggest that there is a high rate of recovery in individuals not receiving somatic treatment of their depressive illness, particularly in the first 3 months of an episode. Because treatment-seeking behavior is known to be associated with a worse prognosis, 23 weeks probably represents a lower-limit approximation of the median duration of an untreated depressive episode.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699380     DOI: 10.1097/01.nmd.0000217820.33841.53

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  18 in total

1.  Improving study design for antidepressant effectiveness assessment.

Authors:  Florian Naudet; Bruno Millet; Jean Michel Reymann; Bruno Falissard
Journal:  Int J Methods Psychiatr Res       Date:  2013-08-30       Impact factor: 4.035

Review 2.  Studies of long-term use of antidepressants: how should the data from them be interpreted?

Authors:  Rif S El-Mallakh; Brian Briscoe
Journal:  CNS Drugs       Date:  2012-02-01       Impact factor: 5.749

3.  Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.

Authors:  Claudio N Soares; Michael E Thase; Anita Clayton; Christine J Guico-Pabia; Kristen Focht; Qin Jiang; Susan G Kornstein; Phillip T Ninan; Cecelia P Kane
Journal:  CNS Drugs       Date:  2011-03       Impact factor: 5.749

4.  The course of major depressive disorder from childhood to young adulthood: Recovery and recurrence in a longitudinal observational study.

Authors:  Maria Kovacs; Scott Obrosky; Charles George
Journal:  J Affect Disord       Date:  2016-05-24       Impact factor: 4.839

5.  Effects of fluoxetine on CRF and CRF1 expression in rats exposed to the learned helplessness paradigm.

Authors:  Georgina Valeria Fernández Macedo; María Laura Cladouchos; Laura Sifonios; Pablo Martín Cassanelli; Silvia Wikinski
Journal:  Psychopharmacology (Berl)       Date:  2012-09-08       Impact factor: 4.530

6.  Seasonal variation of depressive symptoms in unipolar major depressive disorder.

Authors:  Bryan S Cobb; William H Coryell; Joseph Cavanaugh; Martin Keller; David A Solomon; Jean Endicott; James B Potash; Jess G Fiedorowicz
Journal:  Compr Psychiatry       Date:  2014-08-04       Impact factor: 3.735

7.  Work-family conflict, psychological distress, and sleep deficiency among patient care workers.

Authors:  Henrik B Jacobsen; Silje Endresen Reme; Grace Sembajwe; Karen Hopcia; Anne M Stoddard; Christopher Kenwood; Tore C Stiles; Glorian Sorensen; Orfeu M Buxton
Journal:  Workplace Health Saf       Date:  2014-07       Impact factor: 1.413

8.  Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression.

Authors:  Paul W Andrews; Susan G Kornstein; Lisa J Halberstadt; Charles O Gardner; Michael C Neale
Journal:  Front Psychol       Date:  2011-07-07

Review 9.  Characteristics, correlates, and outcomes of childhood and adolescent depressive disorders.

Authors:  Uma Rao; Li-Ann Chen
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

10.  Efficacy of psychodynamic short-term psychotherapy for depressed breast cancer patients: study protocol for a randomized controlled trial.

Authors:  Rüdiger Zwerenz; Manfred E Beutel; Barbara H Imruck; Jörg Wiltink; Antje Haselbacher; Christian Ruckes; Heinz Schmidberger; Gerald Hoffmann; Marcus Schmidt; Uwe Köhler; Dagmar Langanke; Rolf-Dieter Kortmann; Susanne Kuhnt; Gregor Weissflog; Yvette Barthel; Katja Leuteritz; Elmar Brähler
Journal:  BMC Cancer       Date:  2012-12-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.